|
Market Closed -
Australian S.E.
09:20:43 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.670 AUD | +11.25% |
|
+15.09% | +61.33% |
| 09-11 | PYC Therapeutics Says First Patient Dosed in Open-Label Extension of Drug Candidate Study in Polycystic Kidney Disease | MT |
| 09-04 | PYC Therapeutics Limited - Special Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +11.25% | +15.09% | +25.35% | +100.00% | +61.33% | +214.12% | +376.79% | +78.00% | +1,568.75% | 1.68B | |
| +0.11% | +2.71% | -3.57% | +10.98% | +1.45% | +0.33% | +28.59% | -27.10% | +198.14% | 46.18B | |
| -1.24% | +1.68% | +10.88% | +58.64% | +18.08% | +39.93% | +27.13% | +5.13% | +243.96% | 44.35B | |
| -3.32% | -7.09% | -12.35% | +16.16% | +137.70% | +318.69% | +512.12% | +518.32% | - | 42.21B | |
| -1.19% | +0.91% | -5.28% | +29.44% | +15.09% | +1.98% | +67.38% | -12.25% | +1,031.98% | 40.19B | |
| -0.50% | -0.77% | -10.75% | +2.75% | +4.07% | +11.86% | +40.41% | -20.80% | +135.95% | 29.83B | |
| -0.57% | +4.19% | +3.70% | +33.01% | +8.99% | +21.95% | +124.14% | +235.32% | +1,902.40% | 17.17B | |
| +0.05% | -8.95% | -3.59% | +3.94% | - | - | - | - | - | 15.7B | |
| -0.57% | +8.12% | +9.73% | +21.56% | +22.50% | +22.15% | +38.93% | -38.62% | +95.97% | 15.32B | |
| -2.92% | -2.73% | -1.41% | +12.80% | -9.62% | -8.21% | -37.38% | -38.71% | +118.98% | 13.09B | |
| -1.60% | -0.28% | -0.61% | +49.99% | +39.10% | +76.75% | +31.78% | -35.92% | +244.82% | 13.45B | |
| -4.82% | +29.77% | +55.15% | +50.63% | +29.69% | -12.05% | - | - | - | 14.5B | |
| -0.13% | +0.28% | +0.14% | +24.82% | +22.97% | +36.48% | +1.62% | -45.30% | +164.57% | 11.36B | |
| -1.03% | +4.21% | -13.59% | +95.31% | +52.30% | +22.01% | +50.77% | -55.92% | - | 10.98B | |
| -1.27% | +1.67% | -3.71% | +29.24% | +50.21% | +128.45% | +512.23% | +93.21% | - | 9.85B | |
| -0.17% | -3.50% | -9.11% | +26.71% | +63.73% | +130.13% | +710.20% | +1,004.25% | +847.02% | 9.3B | |
| -2.88% | -10.17% | -11.56% | +5.57% | -24.42% | +30.19% | +456.23% | +186.16% | +911.11% | 9.38B | |
| +5.70% | +22.94% | +50.84% | +249.07% | +216.75% | +131.41% | +102.37% | +16.74% | +1,454.94% | 10.82B | |
| -1.22% | +3.60% | +4.04% | +19.16% | -6.99% | -8.55% | -2.77% | -27.89% | +45.20% | 9.18B | |
| -3.93% | -10.88% | -19.38% | +5.62% | +1.16% | +559.24% | +1,299.87% | +7.04% | - | 8.67B | |
| Average | -0.52% | +3.12% | +3.25% | +42.27% | +37.06% | +90.36% | +241.13% | +102.32% | +640.27% | 18.66B | |
| Weighted average by Cap. | -1.13% | +2.85% | +0.74% | +33.74% | +35.88% | +75.81% | +175.53% | +96.77% | +521.83% |
- Stock Market
- Stocks
- PYC Stock
- Sector PYC Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
